Headline: SAWAD makes significant changes to its operational structure, paving the way for the merging of BFIT-SCAP
Srisawad Corporation Plc. (SET: SAWAD) makes significant changes to its operational structure by approving the resolution on the return of finance business license of Srisawad Finance Plc. (SET: BFIT). Coupled with the share swap plan for Srisawad Capital Co., Ltd. (SCAP), whereby SAWAD will reduce its holding in BFIT from 81.64% to 72.05%. Analysts are optimistic about this plan, suggesting SAWAD with a “BUY” rating and a target price of THB78.00.
Headline: SABUY approves the private placement of up to 67 million newly issued ordinary shares
Sabuy Technology Plc. (SET: SABUY) has approved the private placement of 67,639,640 newly issued ordinary shares at a price of THB28.00 per share. THB1,893,91 million worth of newly issued ordinary shares will be allocated to Changyoo Family and COM7 Plc (SET: COM7). SABUY plans to use the proceeds from PP to acquire TSR, TSRL, and DOU7 common stock.
Headline: GLOBAL records a net profit of THB1,163 billion in 1Q22
Siam Global House Plc. (SET: GLOBAL) reported a 1Q22 net profit of THB1,163 million, up 20% year-on-year, meanwhile, total revenues for the quarter were THB9,805.13 million, up 11% year-on-year. The increase was mainly due to its boost in sales and operating costs control.
Headline: JMART acquires 25 million shares of NINE
Jay Mart Plc. (SET: JMART) acquired 25 million shares, or 6.8%, of Nation International Edutainment Plc. (SET: NINE). The chief executive officer of JMART stated that the company would use a tiny amount of money received from the BTS group to cover the capital increase, reiterating the company’s intention to develop its operation on the BTS station, which will include mobile phone sales, lending, and coffee shops.
Headline: BIS debut on the mai index today, analysts recommend “BUY” with a target price of 7.00-8.45
Bioscience Animal Health Plc. (SET: BIS) debuted on the mai index today (May 5), becoming Thailand’s first biotech stock. BIS is a manufacturer and distributor of pharmaceuticals, tools, and livestock and pet goods. Analysts expect a THB119 million net profit for BIS in 2022, increasing 65% year over year, and propose a “BUY” rating with a target price of THB7.00-8.45.
Headline: SET Index sees a rebound, with analysts recommending stocks that profit from a weaker baht
The SET Index is expected to rebound today (May 5) on expectations of a 0.50% rate hike by the Federal Reserve. Analysts believe that if the US Federal Reserve does not signal a significant rate hike, the SET index will rebound, with resistance at 1670 points and support at 1,650 points. As a result, analysts recommend stocks that profit from a weaker baht, such as ASIAN, SAPPE, and MEGA, as well as tourism stocks like AOT CENTEL SPA and MINT.
